NCT02242032View on ClinicalTrials.gov

Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Dry Eye Disease
Interventions
DRUG

P-321 Ophthalmic Solution

DRUG

P-321 Ophthalmic Solution placebo

Placebo to match P-321 Ophthalmic Solution

Trial Locations (1)

90701

Sall Research Medical Center, Artesia

Sponsors

Lead Sponsor

Parion Sciences
All Listed Sponsors
lead

Parion Sciences

INDUSTRY